Lucid Diagnostics (LUCD) Stock: Buy, Sell, or Hold?
LUCD - Lucid Diagnostics Inc. Common Stock
$0.61
-0.03 (-4.21%)
▼
5d:
+3.01%
30d:
-21.94%
90d:
-38.89%
WAIT
LOW Confidence
Analysis Updated: Oct 9, 2026 12:00 AM ET
Earnings: Nov 11, 2026
29d
Get Alerted When LUCD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: LUCD shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: LUCD shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: LUCD is currently trading at $0.61, which is considered oversold relative to its 30-day fair value range of $0.66 to $0.87.
Technical Outlook: Technically, LUCD is in a downtrend. Immediate support is located at $0.50, while resistance sits at $0.83. Short-term momentum is weak, with the stock down 4.2% recently.
Market Sentiment: LUCD scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $4.00 (+527.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, LUCD is in a downtrend. Immediate support is located at $0.50, while resistance sits at $0.83. Short-term momentum is weak, with the stock down 4.2% recently.
Market Sentiment: LUCD scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $4.00 (+527.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.66 -
$0.87
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
89.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (68/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.2%)
- BULLISH: Trading 527.0% below Wall St target ($4.00)
- WARNING: Composite score 49/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.66 -
$0.87
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.50
Resistance Level
$0.83
Current Trend
Downtrend
Technical data as of
Oct 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.87
Wall Street Target
$4.00
(+527.0%)
Revenue Growth (YoY)
26.7%
Share & Embed Analysis
Last updated: October 12, 2026 12:01 PM ET
Data refreshes hourly during market hours. Next update: 1:01 PM
Data refreshes hourly during market hours. Next update: 1:01 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LUCD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
31 analysts |
$60 | 62 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$96 | 54 HOLD |
|
MDT
Medtronic PLC |
BUY
29 analysts |
$104 | 63 BUY |
|
PODD
Insulet Corporation |
BUY
26 analysts |
$171 | 58 HOLD |
|
TNDM
Tandem Diabetes Care Inc |
BUY
25 analysts |
$28 | 58 HOLD |
